AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
about
Recent Advances in Developing Small Molecules Targeting Nucleic AcidHomeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer ProgressionmiRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarksSmall molecule compounds targeting miRNAs for cancer therapyStructure based approaches for targeting non-coding RNAs with small moleculesMicroRNAs and triple negative breast cancerMicroRNAs: novel players in cancer diagnosis and therapies.MicroRNAs expression profile in CCR6(+) regulatory T cellsDicer in immune cell development and function.Differential response of miRNA-21 and its targets after traumatic brain injury in aging mice.Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemnessMultidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas.Macro and small over micro: macromolecules and small molecules that regulate microRNAs.Nonconventional chemical inhibitors of microRNA: therapeutic scope.Selective inhibition of miR-21 by phage display screened peptide.An overview of microRNAsUpregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer.A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing.Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinomaExosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.Small molecules targeting microRNA for cancer therapy: Promises and obstacles.Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy.Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cellsThe Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer.Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.MicroRNA Therapeutics: the Next Magic Bullet?Epithelial-mesenchymal transition in glioblastoma progression.DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer.The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.Signal Peptide Peptidase, Encoded by HM13, Contributes to Tumor Progression by Affecting EGFRvIII Secretion Profiles in Glioblastoma.BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated β-catenin signaling.The Emerging Role of Cdk5 in CancermiR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling.
P2860
Q26744202-00B1F94F-0157-4396-872A-89FE07479ADBQ26768428-0DA383F3-3B14-4B37-9AE7-4EE5416F1CC3Q26781836-30AA69CF-0633-46A2-B8DE-93EBFE705B76Q26829982-9C72C8A4-0C21-4366-B1B3-8174CFC36364Q26858823-44656435-6056-460D-8FCE-77B0FC52DF65Q26862716-8344F6FC-1A67-4054-A84F-6C28E789B4D0Q33914573-1B85B783-AC12-4832-8A11-BF73465FEF3FQ34264939-02ECAEDD-B104-4FA4-BF38-6F066E0A989CQ34389645-1EAC2AF3-B5CC-42ED-A4CC-A965A6993E80Q34773989-84CD78C7-E18C-4D3B-99C5-82A695C80372Q34886908-EB9EB45F-AA63-4B23-BDB4-1E7C4DDEBDEFQ35149628-E3C33F76-33D5-42B2-9435-1412E54080D5Q35163086-152C3641-0D92-4E57-A673-6C8234D3A8DEQ35346350-51D19844-5D4A-4AC9-ADEB-E9573EF07814Q35562046-8242225A-6354-4073-BF4D-94D896F671ECQ35858483-02C454F5-092E-403D-912B-D48760DE3DDAQ35964266-DD6BA71A-3456-4B0E-A152-69EA1F10DE6CQ36009522-296ADF0C-0012-49DA-87D0-4EE37B5939D9Q36299766-0DB0F71D-7AE7-4F6F-818E-ABB5DAC7580CQ36354958-3CEE3F59-0A00-42C2-8755-EDF35FAE2CB3Q36393733-4F5844E9-9F6E-45ED-BC00-71EFDEB15F9CQ36413670-D811C67D-9432-456E-A398-4BFBEC126980Q36498128-C469CEB4-1B2B-47DC-83A8-AF4145251385Q36567511-4B7C96CF-91A3-4425-B473-EC198532CAD3Q36608200-B77AA85E-CCFE-430B-8E22-A37365F8C858Q36624137-76E72BC8-E146-48CB-AD45-5B02F33C2AE5Q37210093-B676C1FC-1E30-43C8-BA33-362A8559C6DDQ37362863-1BE3A2E5-23F0-4249-B8AA-94364EE6B4E4Q37728965-38E3EB19-7564-4CD0-945F-F32862CE6AB8Q38390631-C8A25CAB-C59F-4618-96BF-46D5BF49F143Q38719842-E1D9E3AB-B1B4-4AF9-9040-66999F9648B3Q38737103-0E808EA1-4FAE-4EE2-B992-B20BA73EC427Q38811818-C7920437-BDB3-41A5-A7C3-2A4CE3C13AC5Q38851082-FCE04453-5709-4CE2-817E-5D926C0CAD28Q38951799-2A1944FA-3E90-441C-88A1-2D779EAFC18DQ38960961-7857BBE3-97B9-4147-8184-B24584AAB316Q38997147-C66AA0AC-D8A5-4906-A5A6-08EB333D55B0Q39029140-8990D8A5-2A75-46F6-B2A1-36D28631C41EQ41451321-8A057B5C-E32C-4BAB-85D8-9000D82A048BQ42378357-20380D26-518A-4D1C-80F3-93054CDB9D91
P2860
AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@ast
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@en
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@nl
type
label
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@ast
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@en
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@nl
prefLabel
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@ast
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@en
AC1MMYR2, an inhibitor of dice ...... tumor growth and progression.
@nl
P2093
P1433
P1476
AC1MMYR2, an inhibitor of dice ...... s tumor growth and progression
@en
P2093
Anling Zhang
Chunsheng Kang
Junxia Zhang
Kailiang Zhang
Luyue Chen
Xiaomin Qian
P304
P356
10.1158/0008-5472.CAN-13-0280
P407
P50
P577
2013-06-28T00:00:00Z